| FIDCX | JFDRX | FIDCX / JFDRX | |
| Total Expense Ratio | 1.97 | 0.86 | 229% |
| Annual Report Gross Expense Ratio | 1.98 | 0.87 | 228% |
| Fund Existence | 27 years | 8 years | - |
| Gain YTD | 1.067 | 1.177 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 285M | 285M | 100% |
| Annual Yield % from dividends | 0.26 | 1.25 | 21% |
| Returns for 1 year | -34.21 | -26.69 | 128% |
| Returns for 3 years | -20.66 | -8.13 | 254% |
| Returns for 5 years | -37.22 | -23.40 | 159% |
| Returns for 10 years | -19.75 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CMVRX | 15.47 | 0.17 | +1.11% |
| Columbia Select Mid Cap Value R | |||
| JNGSX | 12.61 | 0.09 | +0.72% |
| Janus Henderson Global Real Estate D | |||
| GSCTX | 13.13 | 0.09 | +0.69% |
| Goldman Sachs Small Cp Val Insghts C | |||
| ABLOX | 22.96 | -0.11 | -0.48% |
| Alger Balanced I-2 | |||
| PRCOX | 68.24 | -0.53 | -0.77% |
| T. Rowe Price U.S. Equity Research | |||